Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davangere P Devanand

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
The Journal of Clinical Psychiatry|August 6, 2014
Whatever happened to new treatments for Alzheimer's disease?Davangere P Devanand
Journal of the American Geriatrics Society|April 2, 2011
A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementiaJ Craig Nelson, Davangere P Devanand
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2023
Vigorous, regular physical exercise may slow disease progression in Alzheimer's diseaseDavangere P Devanand, Arjun V Masurkar, Thomas Wisniewski
Alzheimer Disease and Associated Disorders|November 8, 2016
Impact of Functional Deficits in Instrumental Activities of Daily Living in Mild Cognitive Impairment: A Clinical Algorithm to Predict Progression to DementiaDavangere P Devanand, Xinhua Liu, Patrick J Brown
Alzheimer Disease and Associated Disorders|February 9, 2022
Relapse in Dementia-related Psychosis and Clinical DecisionsMaria Soto-Martin, Erin P Foff, Davangere P Devanand
Journal of Neurology, Neurosurgery, and Psychiatry|November 5, 2020
Associations of APOE e2 genotype with cerebrovascular pathology: a postmortem study of 1275 brainsTerry E Goldberg, Edward D Huey, Davangere P Devanand
Frontiers in Aging Neuroscience|August 1, 2022
Apolipoprotein E Genotype e2: Neuroprotection and Its LimitsHyun Kim, Davangere P Devanand, Scott Carlson, et al.
Current Opinion in Neurology|February 17, 2022
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trialsScott Carlson, Hyun Kim, Davangere P Devanand, et al.
JAMA Psychiatry|February 16, 2022
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related DementiasDavangere P Devanand, Seonjoo Lee, Edward D Huey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2023
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trialsTerry E Goldberg, Seonjoo Lee, Davangere P Devanand, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
The Journal of Clinical Psychiatry|August 6, 2014
Whatever happened to new treatments for Alzheimer's disease?Davangere P Devanand
Journal of the American Geriatrics Society|April 2, 2011
A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementiaJ Craig Nelson, Davangere P Devanand
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 1, 2023
Vigorous, regular physical exercise may slow disease progression in Alzheimer's diseaseDavangere P Devanand, Arjun V Masurkar, Thomas Wisniewski
Alzheimer Disease and Associated Disorders|November 8, 2016
Impact of Functional Deficits in Instrumental Activities of Daily Living in Mild Cognitive Impairment: A Clinical Algorithm to Predict Progression to DementiaDavangere P Devanand, Xinhua Liu, Patrick J Brown
Alzheimer Disease and Associated Disorders|February 9, 2022
Relapse in Dementia-related Psychosis and Clinical DecisionsMaria Soto-Martin, Erin P Foff, Davangere P Devanand
Journal of Neurology, Neurosurgery, and Psychiatry|November 5, 2020
Associations of APOE e2 genotype with cerebrovascular pathology: a postmortem study of 1275 brainsTerry E Goldberg, Edward D Huey, Davangere P Devanand
Frontiers in Aging Neuroscience|August 1, 2022
Apolipoprotein E Genotype e2: Neuroprotection and Its LimitsHyun Kim, Davangere P Devanand, Scott Carlson, et al.
Current Opinion in Neurology|February 17, 2022
Novel approaches to measuring neurocognitive functions in Alzheimer's disease clinical trialsScott Carlson, Hyun Kim, Davangere P Devanand, et al.
JAMA Psychiatry|February 16, 2022
Associations Between Neuropsychiatric Symptoms and Neuropathological Diagnoses of Alzheimer Disease and Related DementiasDavangere P Devanand, Seonjoo Lee, Edward D Huey, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2023
Comparison of relative change with effect size metrics in Alzheimer's disease clinical trialsTerry E Goldberg, Seonjoo Lee, Davangere P Devanand, et al.
Pageof 9